3:35 PM
 | 
Feb 12, 2010
 |  BC Extra  |  Company News

Roche, Artery in APOA1 deal

Artery Therapeutics Inc. (Danville, Calif.) partnered with Roche (SIX:ROG; OTCQX:RHHBY) to co-develop Artery's apolipoprotein A-1 (APOA1) peptide mimetics. The...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >